• A-1331852: BCL-XL Inhibitor Workflows for Advanced Apoptosis

  2026-05-10

  A-1331852 sets a new benchmark for selective BCL-XL inhibition, delivering nanomolar potency in apoptosis assays and preclinical cancer research. This guide details optimized protocols, troubleshooting strategies, and actionable insights for maximizing data reproducibility with A-1331852 from APExBIO.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) Gu

  2026-05-09

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for efficient, low-background capture of biotinylated molecules in workflows such as immunoprecipitation, protein interaction studies, and nucleic acid purification. They are not suitable for applications outside streptavidin–biotin-based separations or those incompatible with hydrophobic bead surfaces.

• GRK Subtype Modulation of M1 Receptor: Mechanisms and Implic

  2026-05-09

  This study dissects how distinct GRK subtypes regulate the biased downstream transducer coupling of the M1 muscarinic acetylcholine receptor (mAChR1), with a focus on the selective allosteric modulator BQCA. Using advanced BRET-based assays, the research reveals a nuanced mechanism by which GRK isoforms determine the receptor's interaction with G proteins and β-arrestin, offering new insight for rational drug design targeting cognitive function and Alzheimer's disease.

• Crizotinib Hydrochloride: ALK Kinase Inhibitor in Cancer Bio

  2026-05-08

  Crizotinib hydrochloride is a potent ALK kinase inhibitor used in cancer biology research to dissect oncogenic signaling pathways. Its efficacy in inhibition of ALK and c-Met phosphorylation is validated in advanced tumor assembloid models, enabling precise study of drug resistance and tumor microenvironment interactions.

• Applied a-MSH, amide Workflows for Pigmentation & Inflammati

  2026-05-07

  APExBIO’s a-MSH, amide empowers researchers to dissect melanogenesis and anti-inflammatory pathways with reproducible, scalable workflows. This guide presents actionable protocols, troubleshooting insights, and comparative analysis to streamline your pigmentation regulation research and melanin synthesis modulation studies.

• Advancing In Vitro Drug Response Metrics in Cancer Research

  2026-05-07

  Schwartz's dissertation critically re-examines how in vitro assays measure anti-cancer drug effects, distinguishing between cell proliferation arrest and cell death. The study introduces more precise evaluation methods that reveal nuanced drug response patterns, with implications for optimizing experimental design and interpreting results in preclinical oncology research.

• Triptolide (PG490): Mechanism-Driven Strategies in Translati

  2026-05-06

  This article explores the multifaceted mechanisms of Triptolide (PG490), emphasizing its pivotal roles as an IL-2/MMP inhibitor and transcriptional modulator. We bridge recent molecular insights, including those from the RBX1/HSF1/AhR axis in inflammation, with strategic recommendations for translational researchers. Drawing on validated protocols and competitive positioning, we highlight how APExBIO's Triptolide empowers cancer and immunology research with reproducibility and mechanistic precision.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract

  2026-05-06

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents proteolytic degradation during protein extraction and sample preparation, ensuring integrity for downstream applications such as Western blot and co-immunoprecipitation. It is not suitable when metalloprotease inhibition via EDTA is required. Use this cocktail in workflows where preservation of native protein structure and compatibility with phosphorylation analysis are critical.

• Betacoronaviruses Modulate the Integrated Stress Response fo

  2026-05-05

  This study by Renner et al. dissects how distinct human betacoronaviruses differentially activate and modulate the integrated stress response (ISR) in lung-derived cell lines. Their findings refine our understanding of viral manipulation of host translational control, with implications for how phosphorylation analysis tools can advance mechanistic studies of viral replication.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-05-05

  DiI (DiIC18(3)) addresses the need for robust, high-contrast plasma membrane labeling in live and fixed cells for workflows such as neuronal tracing and cell migration assays. It is not suitable for protocols that require water solubility or extensive membrane permeabilization. Proper solvent handling and workflow-specific controls are essential for reproducible results.

• Temozolomide in Precision DNA Repair and Glioma Research

  2026-05-04

  Explore how Temozolomide, a potent small-molecule alkylating agent, is transforming DNA repair mechanism research and chemotherapy resistance studies. This article unveils advanced scientific insights and protocol strategies, offering a unique outlook for glioma research.

• Azathramycin A: Mechanistic Insights for Tuberculosis Resear

  2026-05-04

  Explore the mechanistic depth of Azathramycin A, a macrolide antibiotic, with a focus on its ribosome-binding action and advanced utility in tuberculosis research. This article uniquely connects molecular properties to practical assay protocol design.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-03

  This study provides the first detailed molecular mapping of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals during the COVID-19 pandemic in Guangdong, China. The findings elucidate gene prevalence, mobility, and resistance profiles—offering key insights for researchers investigating antimicrobial resistance mechanisms in clinical and laboratory models.

• Toremifene Citrate: Mechanisms, Best Practices, and Impact

  2026-05-02

  This thought-leadership article explores the mechanistic foundation, experimental best practices, and translational impact of Toremifene Citrate as a benchmark oral selective estrogen receptor modulator (SERM) in breast cancer and hormone receptor research. Integrating evidence from clinical and preclinical studies, it offers strategic guidance for translational scientists, and positions APExBIO’s Toremifene Citrate as an essential, rigorously characterized research tool.

• Sabutoclax: Pan-Bcl-2 Inhibitor Driving Quantitative Apoptos

  2026-05-02

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables nuanced quantification of apoptosis in cancer research. This article uniquely bridges advanced in vitro assay science with practical applications for precision drug response measurement.

456 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page